Tori Rodriguez, MA, LPC

The COVID-19 pandemic led to an exacerbation of pre-existing hardships and disparities in many vulnerable populations, including individuals affected by intimate partner violence. We interviewed experts in the field to learn more about this issue and how clinicians may best assist affected individuals.

Although brain stimulation techniques are not considered first-line treatments, these are often used in treatment-resistant depression, with electroconvulsive therapy representing the established best therapeutic option for treatment-resistant depression.

Recent shifts in studies of sex and gender reiterate the critical need to tailor mental health care to each patient and to remain mindful about assumptions regarding sex and gender and their role in a given patient’s specific challenges.

Psychiatrists give insight into managing treatment adherence in schizophrenia.

Researchers weigh in on the use of placebo-controlled trials in schizophrenia.

A newly established center at Johns Hopkins is reinvigorating research on the potential therapeutic applications of psychedelics.

As states pass more restrictive abortion laws, some women may become distressed about the various implications of such legislation and seek support from mental health professionals.

Psychosis spectrum disorder as a diagnosis in place of schizophrenia remains controversial, and experts suggest confusion will continue.

Emerging evidence has begun to elucidate the prevalence and outcomes associated with social anxiety disorder in schizophrenia.

For part 2 of this article, Psychiatry Advisor interviewed Dr Brenda L Curtis, whose research focuses on “big data” generated from social networking sites, technology-based interventions for substance use disorders and related issues, and Internet research ethics.

Both depression and rheumatoid arthritis contribute substantially to global disability, and these diseases often co-occur.

The use of technology is also transforming the mental health landscape, with significant implications for clinicians who work with adolescents, in particular.

Despite record numbers of women working in medicine, instances of gender discrimination and sexual harassment continue to proliferate.

Obesity rates are nearly 40% among US adults, but traditional treatment methods are found to contribute to weight stigma, creating a population that’s unhealthier than ever.

Adolescents infected with HIV have a greater risk for psychiatric hospitalizations compared with those not infected with HIV.

Researchers examined evidence suggesting that probiotics may exert antidepressant effects via anti-inflammatory mechanisms.

The most robust predictive risk factor for BD is a confirmed history of the illness in a first-degree relative, which is associated with an 8-fold to 10-fold lifetime risk for BD and a 2-fold to 3-fold lifetime risk for depressive disorder vs the general population.

These results suggest that the nitrates in cured meat are driving the association between cured meat consumption and mania.

Individuals with comorbid schizophrenia and narcolepsy are exposed to increased prevalence of various risk factors and worse clinical outcomes compared with individuals with either disorder alone.

The focus of mental health policy and treatment for individuals with schizophrenia in the United States has shifted in recent years from stabilization of those with chronic disease to intervention in the early stages of the illness.

Abuse-deterrent opioid formulations have not yet been widely accepted despite their proposed value in reducing opioid abuse and related mortality. Many of the current barriers to broader use are related to their higher cost compared with conventional formulations.

Research has been insufficient to elucidate the prevalence, course, and clinical correlates of rapid cycling in bipolar disorder.

Comorbid depression, when not well controlled, can affect one’s ability to self-manage diabetes. There can be loss of interest in making proper lifestyle choices, monitoring glucose levels, and taking one’s medicines.

There are a number of very plausible hypotheses of what it is about childbirth that is such a potent trigger for severe postpartum episodes in women with bipolar disorder.

An AAEP task force created recommendations for medical evaluation of psychiatric patients presenting to the ED.

New findings suggest that DSM-5 criteria may apply to betel use disorder and offer opportunities to advance the study and understanding of substance use disorder in general.

Increased implementation of integrated primary care could help to improve the availability of psychological treatment for this patient population.

It has been proposed that inflammation stemming from persistent pathogens may influence the development of mood disorders.

Rheuatology Advisor speaks with a psychologist about addressing mental health in patients with inflammatory arthritis.

Endocrinologist Kevin M. Pantalone, DO, and psychiatrist Christian Kohler, MD, discuss the risk associated with the use of antipsychotic medications in individuals with type 2 diabetes.